Companies · Other Health Care

Vesta Medical LLC d/b/a Vestara

Irvine · Other Health Care

Diligence memoA one-page analyst read on Vesta Medical LLC d/b/a Vestara — recommendation, valuation, rhythm, risks.
$19.6M
Total raised · real
6
Rounds
0.4×
Latest step-up
Top 17%
Sector rank · raised
Series A
Latest stage · inferred · Fri May 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time)

Vesta Medical LLC d/b/a Vestara looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.00× the median modeled value of Series A Other Health Care companies in 2007–2009 (48 peers) — value vs value, same stage and era.
  • Within the normal band (100% of peer median) for its niche.
Dormant
  • Last raise 17.1 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Vesta Medical LLC d/b/a Vestara behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
17.1 yr record
Peak capital year was 2009 with $19.6M across 6 filings.
Market position
ahead of 84% of Other Health Care peers
Capital scale is ahead of 84% of Other Health Care peers; modeled value is above 83% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2009: $19.6M across 6 filings.
  • Largest single filing was $6.2M on 2009-05-15.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Vesta Medical LLC d/b/a Vestara is one of 5377 Other Health Care companies tracked from Irvine. By capital raised it ranks in the upper tier (ahead of 84% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeries A · 2009-05-15 Raised $6.2M (real) Modeled valuation $126M (est)$6.2M$126MSeries A2009Series A · 2009-05-15 Raised $4.0M (real) Modeled valuation $82M (est)$4.0M$82MSeries A2009Seed · 2009-05-15 Raised $3.4M (real) Modeled valuation $83M (est)$3.4M$83MSeed2009Seed · 2009-05-15 Raised $2.9M (real) Modeled valuation $73M (est)$2.9M$73MSeed2009Seed · 2009-05-15 Raised $2.1M (real) Modeled valuation $52M (est)$2.1M$52MSeed2009Pre-Seed · 2009-05-15 Raised $890K (real) Modeled valuation $27M (est)$890K$27MPre-Seed2009+$4.0M+$3.4M+$2.9M+$2.1M+$890KCumulative $20M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$6.2M · 2009
Series A extension$4.0M · 2009
Bridge · Series A-stage$3.4M · 2009smaller follow-on
Bridge · Series A-stage$2.9M · 2009smaller follow-on
Bridge · Series A-stage$2.1M · 2009smaller follow-on
Bridge · Series A-stage$890K · 2009smaller follow-on

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$125.6M
Base estimate est.
$8.0M
Conservative case
$683.1M
Upside case
$28.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $125.6M · 2009-05-152009Series A · modeled $81.5M · 2009-05-15Seed · modeled $83.2M · 2009-05-15Seed · modeled $72.6M · 2009-05-15Seed · modeled $52.4M · 2009-05-15Pre-Seed · modeled $27.4M · 2009-05-152009
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
17.1 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
0 mo
Avg between rounds
Capital velocity
17.1 yr
On record since
2009
First round
6
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 8.1× above median
This company$19.6M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.2× of median
This company$890K
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 5.7× above median
This company$125.6M
Sector median$22.1M

Raised more than 84% of sector peers (real $). Modeled value above 83% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #24 of 48.

This companyCohort peer
$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)Dynova Laboratories Inc · Series A Raised $26.0M · modeled $302.7M (est)Vocollect Inc · Series A Raised $15.0M · modeled $302.7M (est)Salient Surgical Technologies, Inc. · Series A Raised $18.4M · modeled $302.7M (est)Orthohelix Surgical Design Inc · Series A Raised $23.4M · modeled $283.2M (est)CardioPolymers, Inc. · Series A Raised $13.6M · modeled $273.9M (est)Natural Dentist Inc · Series A Raised $12.6M · modeled $255.1M (est)Granite Investment Group · Series A Raised $12.5M · modeled $252.2M (est)Portaero, Inc · Series A Raised $11.8M · modeled $238.5M (est)Prematics Inc · Series A Raised $10.8M · modeled $217.7M (est)Replenish, Inc. · Series A Raised $10.2M · modeled $206.8M (est)Wellsense Technologies LLC · Series A Raised $9.2M · modeled $185.0M (est)Docusys Inc · Series A Raised $8.8M · modeled $178.4M (est)Vesta Medical LLC d/b/a Vestara (this company) Raised $19.6M · modeled $125.6M (est)Vesta Medical LLC d/b/a Vestara
CompanyStageRaised · realValue · estvs peer med.
Dynova Laboratories IncSeries A$26.0M$302.7M2.42×
Vocollect IncSeries A$15.0M$302.7M2.42×
Salient Surgical Technologies, Inc.Series A$18.4M$302.7M2.42×
Orthohelix Surgical Design IncSeries A$23.4M$283.2M2.26×
CardioPolymers, Inc.Series A$13.6M$273.9M2.19×
Natural Dentist IncSeries A$12.6M$255.1M2.04×
Granite Investment GroupSeries A$12.5M$252.2M2.02×
Portaero, IncSeries A$11.8M$238.5M1.91×
Prematics IncSeries A$10.8M$217.7M1.74×
Replenish, Inc.Series A$10.2M$206.8M1.65×
Wellsense Technologies LLCSeries A$9.2M$185.0M1.48×
Docusys IncSeries A$8.8M$178.4M1.43×
Vesta Medical LLC d/b/a Vestara this companySeries A$19.6M$125.6M1.00×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$6.2M2009-05-15$28.3M$125.6M90%
Series A$4.0M2009-05-15$18.4M$81.5M90%
Seed$3.4M2009-05-15$16.8M$83.2M90%
Seed$2.9M2009-05-15$14.7M$72.6M90%
Seed$2.1M2009-05-15$10.6M$52.4M90%
Pre-Seed$890K2009-05-15$4.9M$27.4M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$6.2M2009-05-15
    • First recorded raise — entered as Series A.
  2. Series A$4.0M2009-05-15
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× smaller than the prior — bridge or down round.
  3. Seed$3.4M2009-05-15
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  4. Seed$2.9M2009-05-15
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  5. Seed$2.1M2009-05-15
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.4× smaller than the prior — bridge or down round.
  6. Pre-Seed$890K2009-05-15
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.4× smaller than the prior — bridge or down round.
Intelligence
Modeled next raise
$890K
Modeled next size est.range $890K$1.4M
0.4×
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Robert Morris6 other2009-05
Arthur Bertolero4 other2009-05
William E. Maya3 other2009-05
Alan Davidner2 other2009-05
John K Stroh1 other2009-05
Michael J Greer1 other2009-05
Michael J Martin1 other2009-05
Alan E Davidner2009-05
Arthur K Bertolero2009-05
Arthur R Bertolero2009-05
Robert J Morris2009-05
Scott R Mallett2009-05
Registry & provenance

Vesta Medical LLC d/b/a Vestara is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1369354
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Neomatrix LlcOther Health CareSeries A$12.0M$85.3Mnetwork5 shared operators · same sector · same stage
ExsoMed CorpOther Health CareSeries A$15.7M$180.0Mnetwork1 shared operator · same sector · same stage
Endoclear LLCOther Health CareSeed$6.4M$19.4Mnetwork2 shared operators · same sector
Akshay Wellness, Inc.Other Health CareSeries A$19.8M$126.9Msame sector · same stage
Cayenne Medical IncOther Health CareSeries A$19.8M$100.9Msame sector · same stage
SmartyPants, Inc.Other Health CareSeries A$19.3M$136.0Msame sector · same stage
Informed Medical Decisions, Inc.Other Health CareSeries A$19.2M$131.2Msame sector · same stage
Insightra Medical, Inc.Other Health CareSeries A$20.0M$100.9Msame sector · same stage
Frequently asked
How much funding has Vesta Medical LLC d/b/a Vestara raised?
Vesta Medical LLC d/b/a Vestara has raised approximately $19.6M in disclosed capital across 6 recorded financing rounds, aggregated from public filings.
What is Vesta Medical LLC d/b/a Vestara's estimated valuation?
Provath's modeled valuation for Vesta Medical LLC d/b/a Vestara is approximately $125.6M (modeled range $8.0M–$683.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Vesta Medical LLC d/b/a Vestara at?
Vesta Medical LLC d/b/a Vestara's latest modeled financing stage is Series A. Its most recent recorded round closed around Fri May 15.
What does Vesta Medical LLC d/b/a Vestara do and where is it based?
Vesta Medical LLC d/b/a Vestara operates in the Other Health Care sector, based in Irvine.
Explore related

See where Vesta Medical LLC d/b/a Vestara sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Vesta Medical LLC d/b/a Vestara, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.